EMN

Eastman Chemical Company - 10-Q Summary (Q2 2007)

Business Context and Reporting Period

This filing covers the quarterly period ended June 30, 2007. Eastman Chemical Company operates in five reportable segments: Coatings, Adhesives, Specialty Polymers and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and Specialty Plastics (SP). The company is a large accelerated filer incorporated in Delaware.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Sales decreased 2% in Q2 and 1% YTD compared to the prior year. This decline is primarily due to the divestiture of polyethylene (PE) product lines and the San Roque, Spain PET facility in late 2006. Excluding divested lines and contract ethylene sales, organic sales increased 6% in Q2 and 8% YTD.
• Profitability Pressure: Operating earnings fell 12% in Q2 and 19% YTD. This was driven by higher raw material and energy costs (up ~$50 million in Q2 and ~$100 million YTD), accelerated depreciation of $14 million (Q2) and $28 million (YTD), and asset impairment/restructuring charges of $2 million (Q2) and $23 million (YTD).
• Segment Performance:
  • PCI: Sales increased 28% YTD, driven by contract ethylene sales and strong demand for olefin-based derivatives.
  • Performance Polymers: Sales decreased 24% YTD due to divestitures. The segment reported an operating loss of $64 million YTD, heavily impacted by a $22 million impairment charge related to the Spain PET facility and $13 million in accelerated depreciation.
  • Fibers: Operating earnings declined 13% YTD due to lower volumes in acetate tow and higher wood pulp costs.
• Cash Flow: Operating cash flow decreased $64 million YTD, primarily due to a $100 million contribution to U.S. defined benefit pension plans (compared to $50 million in the prior year).

Guidance, Outlook, and Risks

• 2007 Outlook: Management expects strong volumes but continued volatility in raw material and energy costs. They anticipate approximately $50 million in accelerated depreciation costs for the full year 2007.
• Capital Allocation: Priorities include paying quarterly dividends, funding growth initiatives (including two new industrial gasification projects), and share repurchases. The company repurchased $86 million of stock YTD and has $214 million remaining under its $300 million authorization.
• Strategic Actions: The company is evaluating strategic options for underperforming PET facilities outside the U.S., which may lead to further restructuring or divestiture. The new IntegRex PET facility in South Carolina is fully operational.
• Risks: Key risks include raw material availability and cost volatility, foreign currency exchange fluctuations, and potential impacts from legal proceedings (including sorbates and asbestos litigation), though management does not expect these to be material to overall financial condition.

Investor Verification Checklist

• Divestiture Impact: Verify the extent to which reported declines are due to one-time divestitures versus organic operational weakness, particularly in the Performance Polymers segment.
• Cost Pass-Through: Assess the company's ability to sustain price increases to offset the significant rise in raw material and energy costs noted in the filing.
• Restructuring Costs: Monitor for additional asset impairment or restructuring charges related to the ongoing evaluation of non-U.S. PET facilities.
• Pension Funding: Confirm that the $100 million pension contribution was a one-time event for 2007, as management indicated no further contributions are planned for the year.
• Capital Expenditures: Track progress on the $500 million expected capital spending for 2007, specifically the gasification projects and IntegRex enhancements.